Lucaciu, L. A., Ilieș, M., Vesa, Ș. C., Seicean, R., Din, S., Iuga, C. A., & Seicean, A. (2021). Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease. MDPI AG.
Cita Chicago Style (17a ed.)Lucaciu, Laura A., Maria Ilieș, Ștefan C. Vesa, Radu Seicean, Shahida Din, Cristina Adela Iuga, y Andrada Seicean. Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate Between Severe and Non-Severe Disease. MDPI AG, 2021.
Cita MLA (8a ed.)Lucaciu, Laura A., et al. Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate Between Severe and Non-Severe Disease. MDPI AG, 2021.